MYOBLOC BOTULINUM TOXIN TYPE B INJECTABLE SOLUTION
Dead / Cancelled — Cancelled — Section 8 (as of 30 May 2009)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 78039531
- Registration number
- 2639583
- Mark type
- Design + words
- Filed
- 15 Dec 2000
- Published for opposition
- 30 Jul 2002
- Registered
- 22 Oct 2002
- Attorney of record
- Laura Newman Sciarrino
Goods and services
- Class 005 — Pharmaceuticals: PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS
Owner
- SOLSTICE NEUROSCIENCES, INC., MALVERN, PA, US
- Elan Pharmaceuticals, Inc., South San Francisco, CA, US
- Elan Pharmaceuticals, Inc., South San Francisco, CA, US
- Elan Pharmaceuticals, Inc., South San Francisco, CA, US
Prosecution history
- 18 Aug 2010 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 30 May 2009 — CANCELLED SEC. 8 (6-YR)
- 29 Nov 2007 — CASE FILE IN TICRS
- 17 May 2005 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 22 Oct 2002 — REGISTERED-PRINCIPAL REGISTER
- 30 Jul 2002 — PUBLISHED FOR OPPOSITION
- 10 Jul 2002 — NOTICE OF PUBLICATION
- 01 Jun 2002 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 May 2002 — PREVIOUS ALLOWANCE COUNT WITHDRAWN
- 22 May 2002 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 May 2002 — EXAMINERS AMENDMENT E-MAILED
- 22 May 2002 — USE AMENDMENT ACCEPTED
- 05 Mar 2002 — AMENDMENT TO USE PROCESSING COMPLETE
- 07 Dec 2001 — USE AMENDMENT FILED
- 07 Dec 2001 — CORRESPONDENCE RECEIVED IN LAW OFFICE